CNU has succeeded in developing nanoparticles that kill cancer cells by reacting to active radicals from human cancer cells.

CNU announced on January 2nd that the research of Professor Park In-kyu (Department of Biomedical Sciences) successfully developed photoactivable nanomicelles that kill cancer cells while being decomposed by free radicals from tumors through joint research with Professor Bae Woo-kyun (CNU Hospital in Hwasoon), and Professor Huh Kang-moo (Chungnam National University).
 
It is known that most of the modern diseases commonly seen around us, such as cancer, chronic inflammation, strokes, and myocardial infarction, are related to active radicals. The photoactivable nanomicelles developed by the research team of Professor Park respond to these active radicals, selectively approach cancerous tumors and release drugs and photodynamic therapeutics to kill cancer cells. It is also possible to combine drug and photodynamics therapy with existing anticancer therapies, which can greatly improve the existing anticancer therapeutic effects.

Based on the results of this study, the research team will expand the development into a fundamental treatment for intractable cancers by combining conventional treatments of radiation therapy and immunotherapy technology. In addition, it will further the research into the technological development of the selective release of therapeutic material to inflammatory diseases such as Parkinson's, Alzheimer's disease, or sepsis. Furthermore, the research team will apply for domestic and overseas patents for commercialization.
 
 The results of the research were published in the online edition of Biomaterials (Influence Index 10.273), which ranks top 1% in the field of SCI biomaterials field.